News about Digitalization

GAIA AG and Daiichi Sankyo Europe Partner to Commercialise Digital Therapeutic for Cholesterol Management

GAIA AG and Daiichi Sankyo Europe form an exclusive partnership to commercialise lipodia, a digital therapeutic designed to help adults with Hypercholesterolemia adopt sustainable lifestyle changes for improved cardiovascular health.

Digitalization | 07/03/2026 | By News Bureau |  201

Biocon Academy Launches AI Certificate Programme in Life Sciences

Biocon Academy has launched the Syngene IBAB Certificate Programme in Artificial Intelligence in Life Sciences (SAILS), a first-of-its-kind initiative designed to build future-ready, industry-aligned AI talent for the life sciences sector and strengthen the intersection of biotechnology and digital innovation.

Digitalization | 05/03/2026 | By Akanki |  599

India-Rwanda Discussions Focus on AI, Bio-Manufacturing and Emerging Technologies

Union Minister Dr Jitendra Singh held talks with Rwanda’s ICT leadership to explore collaboration in Artificial Intelligence (AI), genomics, nuclear energy and deep-tech, highlighting startup partnerships and knowledge exchange to strengthen India-Rwanda cooperation.

Digitalization | 23/02/2026 | By News Bureau |  246

FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes

Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.

Digitalization | 22/01/2026 | By News Bureau |  287

HistoIndex, Houston Research Institute Collaborate to Enhance MASH Diagnosis Using AI

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has entered into a strategic partnership with Houston Research Institute (HRI), a leading clinical research organization specialising in hepatology and gastroenterology, with a strong focus on metabolic liver disease.

Digitalization | 22/01/2026 | By Darshana |  170

Graph Therapeutics Taps Parse GigaLab to Accelerate AI-First Immunology Drug Discovery

Parse Biosciences and Graph Therapeutics have entered into a strategic partnership to build one of the largest and most comprehensive immune cell perturbation atlases to date.

Digitalization | 22/01/2026 | By Darshana |  228

HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care

HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.

Digitalization | 21/01/2026 | By News Bureau |  290

PharmaCloud Bridges Innovation and Compliance in Pharma Manufacturing Operations

Pharma manufacturing continues to grapple with a long-standing challenge: balancing innovation with strict regulatory compliance. While AI-driven technologies have the potential to significantly enhance operator capability and execution consistency, their adoption on the shop floor is often constrained by regulatory and validation requirements.

Digitalization | 20/01/2026 | By Darshana |  253

Viz.ai Launches Real-Time Clinical Intelligence Service for Salesforce Agentforce Life Sciences

The new service integrates Viz.ai’s real-time clinical data from nearly 2,000 hospitals to power intelligent, closed-loop agentic workflows for life sciences organisations.

Digitalization | 16/01/2026 | By News Bureau |  413

Illumina Launches Billion Cell Atlas to Power AI-Driven Drug Discovery

Illumina, Inc. has launched the Illumina Billion Cell Atlas, the world’s largest genome-wide genetic perturbation dataset, designed to accelerate AI-enabled drug discovery across the pharmaceutical industry.

Digitalization | 15/01/2026 | By Darshana |  297